Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Gitau

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Missouri Medicine|February 28, 2009
Heparin-induced thrombocytopeniaMark M Gitau, Navanshu Arora
Surgery Open Science|September 21, 2020
Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology programJonathan S Bleeker, Christopher J Sumey, Steven F Powell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2020
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB StudySteven F Powell, Kathryn A Gold, Mark M Gitau, et al.
JCO Precision Oncology|February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational StudySteven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Missouri Medicine|February 28, 2009
Heparin-induced thrombocytopeniaMark M Gitau, Navanshu Arora
Surgery Open Science|September 21, 2020
Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology programJonathan S Bleeker, Christopher J Sumey, Steven F Powell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2020
Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB StudySteven F Powell, Kathryn A Gold, Mark M Gitau, et al.
JCO Precision Oncology|February 9, 2022
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational StudySteven F Powell, Elie G Dib, Jonathan S Bleeker, et al.
Pageof 1